Search
Daratumumab
Daratumumab is an immunoglobulin G1 kappa monoclonal antibody developed by Janssen and Genmab. It was first described in the literature in 2010 as a monoclonal antibody that targets CD38+ multiple myeloma cells; the first of its kind. Daratumumab was granted FDA approval on 16 November 2015. It is approved for the t...
Iberdomide
go.drugbank.com/drugs/DB12101ApprovedInvestigational[L64055,L64057] It is given in combination with daratumumab and hyaluronidase-fihj and dexamethasone. … [L64055] The FDA granted iberdomide accelerated approval on August 13, 2026, in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received
High risk Smoldering Multiple Myeloma (SMM)
go.drugbank.com/conditions/DBCOND0154757Drugs: DaratumumabCarfilzomib
go.drugbank.com/drugs/DB08889ApprovedInvestigationalCarfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved carfilzomib in July 2012 for the treat...
Isatuximab
go.drugbank.com/drugs/DB14811ApprovedInvestigational[L12099] Along with [daratumumab], another anti-CD38 mAb, isatuximab constitutes a novel treatment modality for patients with difficult-to-treat multiple myeloma.
Teclistamab
go.drugbank.com/drugs/DB16655ApprovedInvestigationalTeclistamab is an IgG4-PAA bispecific antibody that targets the CD3 receptor expressed on the surface of T cells and B cell maturation antigen (BCMA) expressed on malignant multiple myeloma cells. Teclistamab consists of an anti-BCMA arm...
Primary Amyloidosis
go.drugbank.com/conditions/DBCOND0040057Drugs: Bortezomib · Cyclophosphamide · Daratumumab · Dexamethasone · Hyaluronidase (human recombinant) · Lenalidomide +1 moreCiltacabtagene autoleucel
go.drugbank.com/drugs/DB16738ApprovedInvestigational[daratumumab]), although none are curative.
Relapsed Multiple Myeloma
go.drugbank.com/conditions/DBCOND0031510Drugs: Belantamab mafodotin · Carfilzomib · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone · Elranatamab +8 moreRefractory Multiple Myeloma
go.drugbank.com/conditions/DBCOND0028542Drugs: Belantamab mafodotin · Carfilzomib · Carmustine · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone +11 more